glp-1 hub podcast In this week's episode of the podcast, Dr. Francavilla and I discuss the importance of muscle health in the context of GLP-1 medications and weight loss. She explains the role The Truth About GLP-1s: What

Protect, brighten, firm

Key risks recognised in UK clinical practice include: Reduced efficacy of adrenaline during anaphylaxis, as propranolol blunts the beta-2 bronchodilatory response

Available data suggest that these substances are capable of crossing the BBB (Zhang et al., 1998

Glucagon receptor (GCG) activation adds: Effects: Increases energy expenditure Promotes fat oxidation (burning fat for fuel) Signals satiety through brain-gut communication May enhance liver fat reduction Potentially greater effects on body composition The glucagon component matters: Research shows that glucagon signaling through the vagal nerve creates feelings of fullness, and glucagon receptor activation in the liver stimulates FGF21 secretiona hormone that helps burn fat without necessarily reducing food intake